Siltuximab Alternatives Compared
Siltuximab | Sylvant (siltuximab) |
|
---|
Siltuximab | Sylvant (siltuximab) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Multicentric Castleman’s Disease. Siltuximab may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Multicentric Castleman’s Disease. Sylvant may also be used for purposes not listed in this medication guide. |
||||||||
More about Siltuximab | More about Sylvant (siltuximab) | ||||||||
Ratings & Reviews | |||||||||
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Siltuximab side effects |
View all Sylvant side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Sylvant prices |
||||||||
Dosage Forms | |||||||||
N/A |
|
||||||||
Brand Names | |||||||||
Sylvant |
N/A |
||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
712.8 hours |
712.8 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 317 drugs are known to interact with Siltuximab:
|
A total of 317 drugs are known to interact with Sylvant:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
April 23, 2014 |
April 23, 2014 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Sylvant
Sylvant (siltuximab) is used to treat multicentric Castleman’s disease. Includes Sylvant side e ...
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Adbry
Adbry is used to treat moderate-to-severe atopic dermatitis (eczema) in adults and children aged 12 ...
Arcalyst
Arcalyst (rilonacept) is used to treat Cryopyrin-Associated Periodic Syndromes, Deficiency of ...
Bimzelx
Bimzelx (bimekizumab) treats plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and ...
Cinqair
Cinqair (reslizumab) is a monoclonal antibody that affects the actions of the body's immune system ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Ebglyss
Ebglyss (lebrikizumab) is a treatment for moderate-to-severe atopic dermatitis given as a monthly ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.